Recent DNLI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:03:33 PM
- Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 05/07/2024 08:01:00 PM
- Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/01/2024 09:51:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:07:37 PM
- Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights • GlobeNewswire Inc. • 02/27/2024 01:05:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:03:38 PM
- Denali Therapeutics Announces $500 million Private Placement Equity Financing • GlobeNewswire Inc. • 02/27/2024 01:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 01:02:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:15:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:14:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:14:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 09:59:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 09:43:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 01:19:50 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 01:18:42 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 01:17:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:48:27 PM
- Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™ • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™ • GlobeNewswire Inc. • 02/01/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 01:18:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 10:28:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/10/2024 09:09:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:35:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:34:07 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM